Your browser doesn't support javascript.
loading
MTOR inhibitor-based combination therapies for pancreatic cancer.
Hassan, Zonera; Schneeweis, Christian; Wirth, Matthias; Veltkamp, Christian; Dantes, Zahra; Feuerecker, Benedikt; Ceyhan, Güralp O; Knauer, Shirley K; Weichert, Wilko; Schmid, Roland M; Stauber, Roland; Arlt, Alexander; Krämer, Oliver H; Rad, Roland; Reichert, Maximilian; Saur, Dieter; Schneider, Günter.
Affiliation
  • Hassan Z; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
  • Schneeweis C; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
  • Wirth M; Institute of Pathology, Heinrich-Heine University and University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
  • Veltkamp C; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
  • Dantes Z; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
  • Feuerecker B; Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
  • Ceyhan GO; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • Knauer SK; Department of Surgery, Klinikum rechts der Isar, Technical University of Munich, 81675 München, Germany.
  • Weichert W; Molecular Biology, Centre for Medical Biotechnology (ZMB), University Duisburg-Essen, 45141 Essen, Germany.
  • Schmid RM; Institute of Pathology, Technische Universität München, 81675 München, Germany.
  • Stauber R; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
  • Arlt A; Molecular and Cellular Oncology/ENT, University Medical Center Mainz, Langenbeckstrasse 1, Mainz 55131, Germany.
  • Krämer OH; Laboratory of Molecular Gastroenterology and Hepatology, 1st Department of Internal Medicine, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Rad R; Department of Toxicology, University of Mainz Medical Center, Mainz 55131, Germany.
  • Reichert M; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
  • Saur D; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.
  • Schneider G; Medical Clinic and Polyclinic II, Klinikum rechts der Isar, Technical University Munich, 81675 München, Germany.
Br J Cancer ; 118(3): 366-377, 2018 02 06.
Article in En | MEDLINE | ID: mdl-29384525
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / MAP Kinase Signaling System / Carcinoma, Pancreatic Ductal / TOR Serine-Threonine Kinases Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2018 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / MAP Kinase Signaling System / Carcinoma, Pancreatic Ductal / TOR Serine-Threonine Kinases Limits: Animals / Humans Language: En Journal: Br J Cancer Year: 2018 Type: Article Affiliation country: Germany